Press release
Colorectal Cancer Screening Market size was valued at USD 15 Billion in 2021, growing at a CAGR of 5.4% from 2022 to 2032: Evolve Business Intelligence
Request Free Sample Report or PDF Copy: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=016339
Key Highlights:
• The global Colorectal Cancer Screening market size was valued at USD 15 Billion in 2021 growing at the CAGR of 5.4% from 2022 to 2032.
• North America dominated the market in 2021
• Asia Pacific is expected to grow at a highest CAGR from 2022 to 2032
Key Players
The Colorectal Cancer Screening market report gives comprehensive information about the company and its past performance. The report also provide a detail market share analysis along with product benchmarking with key developments.
The key players profiled in the report are:
● NOVIGENIX SA
● EIKEN CHEMICAL CO., LTD.
● Clinical Genomics Technologies Pty Ltd.
● Exact Sciences Corporation
● Epigenomics AG
● bioMérieux, Inc.
● Olympus Corporation
● KARL STORZ SE & Co. KG
● FUJIFILM Holdings America Corporation
The Global Colorectal Cancer Screening Logistic report also includes information on company profiles, product descriptions, revenue, market share data, and contact details for several regional, global, and local companies. Due to increased technological innovation, R&D, and M&A operations in the sector, the market is becoming more popular in particular niche sectors. Additionally, a large number of regional and local vendors in the Colorectal Cancer Screening market provide specialised product offerings according to geographical regions in keeping with the global manufacturing footprint. Due to the reliability, quality, and technological modernity of the worldwide suppliers, it is difficult for the new market entrants to compete.
COVID Impact
In terms of COVID 19 impact, the Colorectal Cancer Screening market report also includes the following data points:
● COVID19 Impact on Colorectal Cancer Screening market size
● End-User/Industry/Application Trend, and Preferences
● Government Policies/Regulatory Framework
● Key Players Strategy to Tackle Negative Impact/Post-COVID Strategies
● Opportunity in the Colorectal Cancer Screening market
Get a Free Sample Copy of This Report @ https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=016339
Scope of the Report:
Market Segment By Type:
o Stool-based Tests (Fecal Immunochemical Test (FIT)
o Fecal Occult Blood Test (FOBT)
o Stool-DNA Test), Colonoscopy
o Others
Market Segment By End User:
o Hospitals & Clinics
o Clinical Laboratories
o Diagnostics Imaging Centers
o Others
For more information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=016339
Key Region/ Countries Covered
● North America (US, Canada, Mexico)
● Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
● Asia-Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
● Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of MEA)
● Latin America (Mexico, Brazil, Argentina, Rest of Latin America)
Reasons to Buy this Report:
• Detail analysis of the impact of market drivers, restraints, and oppotunities
• Competitive Intelligence providing the understanding about the ecosystem
• Details analysis of Total Addressable Market (TAM) of your products
• Investment Pockets and New Business Opportunities
• Demand-supply gap analysis
• Strategy Planning
Contact Us:
Evolve Business Intelligence
India
Contact: +1 773 644 5507 (US) / +441163182335 (UK)
Email: sales@evolvebi.com
Website: www.evolvebi.com
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging the pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Colorectal Cancer Screening Market size was valued at USD 15 Billion in 2021, growing at a CAGR of 5.4% from 2022 to 2032: Evolve Business Intelligence here
News-ID: 2791902 • Views: …
More Releases from Evolve Business Intelligence
Physical Security Market Forecast to Reach USD 263.32 Billion by 2033
The global physical security market is undergoing a significant transformation, driven by a convergence of technological advancements and evolving security threats. Within this landscape, Video Surveillance as a Service (VSaaS) is emerging as a high-opportunity solution, poised to redefine how businesses and organizations protect their assets. This article explores the challenges facing the market and presents VSaaS as a pragmatic and effective solution, while also considering external factors like US…
Over-the-Top (OTT) Market Forecast to Reach USD 476.84 Billion by 2033
The Over-the-Top (OTT) market is a digital gold rush, bypassing traditional media distribution to deliver content directly to consumers via the internet. As per a recent analysis by Evolve Business Intelligence, this dynamic market is projected to reach a staggering USD 476.84 billion by 2033, with a robust compound annual growth rate (CAGR) of 16.74% from 2023. While smartphones and smart TVs currently dominate this landscape, a significant, often overlooked…
Modular Data Center Market Forecast to Reach USD 75.77 Billion by 2030
The global modular data center market, valued at an estimated $29.04 billion in 2024, is on a rapid growth trajectory, projected to reach $75.77 billion by 2030, with a compound annual growth rate (CAGR) of 17.4%. While this growth is fueled by major sectors like IT, telecom, and healthcare, the retail industry stands out as a high-opportunity niche poised to leverage modular data center solutions.
Download the full report now to…
Medical Device Security Market Forecast to Reach USD 13.58 Billion by 2033
The medical device industry is undergoing a digital transformation, with an increasing number of devices connecting to the internet and healthcare networks. This evolution has created a significant market for medical device security, which is projected to grow from USD 6.47 billion in 2023 to USD 13.58 billion by 2033, at a robust Compound Annual Growth Rate (CAGR) of 8.24%. At the core of this growth lies a critical and…
More Releases for Colorectal
Metastatic Colorectal Cancer Therapeutics Market - Innovation in Motion: Elevate …
Newark, New Castle, USA: The "Metastatic Colorectal Cancer Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Metastatic Colorectal Cancer Therapeutics Market: https://www.growthplusreports.com/report/metastatic-colorectal-cancer-therapeutics-market/8685
This latest report researches the…
Potential Opportunities of Colorectal Cancer Therapeutics Market
The global colorectal cancer therapeutics market size is projected to reach USD 16.58 billion by 2026, owing to the rise in the prevalence of colorectal cancer worldwide. A report by Fortune Business Insights(TM) titled, "Colorectal Cancer Therapeutics Market Size, Share & Industry Analysis, By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, Others), By Cancer Type (Colorectal Adenocarcinoma, Gastrointestinal Carcinoid Tumors, Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and…
Colorectal Cancer Pipeline Therapeutic Review H1 2017
Colorectal Cancer Pipeline Review H1 2017 provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is cancer that starts in the large intestine (Colorectal). There is no single cause of colorectal cancer. Nearly all colorectal cancers begin as noncancerous (benign) polyps, which slowly develop into cancer.
For More on Colorectal Cancer Pipeline Review H1 2017 Report Inquire @
https://goo.gl/1HQ4Fn .
Report Description:
Pharmaceutical guide Colorectal Cancer - Pipeline Review H1…
US Colorectal Cancer Drug Pipeline Analysis
Among all the regions affected with colorectal cancer, the US would continue to account for a giant’s share owing to its huge population base. With regards to rates of increase, it is most likely that the US would witness a modest increase in the prevalence of the disease, mostly as a result of the country having already reached epidemic proportions of the disease. According to estimates, approximately 55,000 people die…
Colorectal Cancer - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Colorectal Cancer - Heat Map and Analysis to its growing collection of premium market research reports.
Colorectal cancer (CRC), otherwise known as bowel cancer, is a malignancy originating in the colon (the large intestine) or rectum, both of which are located towards the end of the human gastrointestinal tract. It begins as a benign tumor, which is almost always in…
Colorectal Cancer Treatment Market- Global Outlook 2024
Colorectal cancer is cancer that starts in the colon or rectum. The colon and the rectum are parts of the large intestine, which is the lower part of the body’s digestive system. The colon absorbs water and nutrients from the food and stores waste matter (stool). Stool moves from the colon into the rectum before it leaves the body. Colorectal cancer often begins as a growth called a polyp, which…
